CapIri

Indication

Chemotherapy for stage IV (metastatic) cancer

• Capecitabine (Xeloda) 1000 mg/m2 po bid x 14 days
• Irinotecan (Camptosar, CPT-11) 100 mg/m2 iv d1, 8
• Q22d

References

Grothey A, et al. Capecitabine/irinotecan (CapIri) and capecitabine/oxaliplatin (CapOx) are active second-line protocols in patients with avdanced colorectal cancer (ACRC) after failure of first-line combination therapy: results of a randomized phase II study. 2004 ASCO annual meeting. Abstract 3534